You are here

  • Home
  • Archive
  • Volume 2, Issue 1
  • Bivalirudin versus unfractionated heparin: a meta-analysis of patients receiving percutaneous coronary intervention for acute coronary syndromes

Article info

Article menu
Interventional cardiology
Original research article
Bivalirudin versus unfractionated heparin: a meta-analysis of patients receiving percutaneous coronary intervention for acute coronary syndromes

Authors

  • Mohamed Farag Department of Cardiology, East and North Hertfordshire NHS Trust, Hertfordshire, UK Postgraduate Medical School, University of Hertfordshire, Hertfordshire, UK PubMed articlesGoogle scholar articles
  • Diana A Gorog Department of Cardiology, East and North Hertfordshire NHS Trust, Hertfordshire, UK Postgraduate Medical School, University of Hertfordshire, Hertfordshire, UK National Heart & Lung Institute, Imperial College, London, UK PubMed articlesGoogle scholar articles
  • Abhiram Prasad Cardiovascular and Cell Sciences Research Institute, St George's, University of London, London, UK PubMed articlesGoogle scholar articles
  • Manivannan Srinivasan Department of Cardiology, East and North Hertfordshire NHS Trust, Hertfordshire, UK PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Manivannan Srinivasan; manivannan.srinivasan{at}nhs.net
View Full Text

Citation

Farag M, Gorog DA, Prasad A, et al
Bivalirudin versus unfractionated heparin: a meta-analysis of patients receiving percutaneous coronary intervention for acute coronary syndromes
Open Heart 2015;2:e000258. doi: 10.1136/openhrt-2015-000258

Publication history

  • Received April 3, 2015
  • Revision received August 7, 2015
  • Accepted August 27, 2015
  • First published October 1, 2015.
Online issue publication 
April 30, 2020

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/